0.1 andr syrota
•Download as PPT, PDF•
1 like•385 views
The document summarizes the goals and activities of Aviesan, the French Alliance for Life and Health Sciences. It aims to optimize scientific foresight, facilitate research clusters, and promote national projects. It represents major French research organizations and operates through 10 thematic institutes. It also maintains a catalog of 237 French health databases and supports several large research projects and infrastructures through funding from "Investments for the future", totaling billions of euros over 10 years.
Report
Share
Report
Share
![The French Alliance for Life and Health Sciences: Aviesan ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommended
HIPBI-RD: Harmonising phenomics information for a better interoperability in ...
HIPBI-RD: Harmonising phenomics information for a better interoperability in ...Human Variome Project
Rare disease (RD) research is a field of medicine increasingly reliant on information technology, with the advent of low-cost whole-genome sequencing revolutionising the discovery of genetic causes of disorders. Detailed phenotype data, combined with genomic data, have an enormous potential to accelerate the identification of clinically actionable prognostic or therapeutic implications and to improve our understanding of RD. The harmonisation of phenomics information, including disorders and phenotype traits that are stored in different contexts in a non-standardised way, is a cornerstone for producing sound data to foster research.
HIPBI-RD («Harmonising phenomics information for a better interoperability in the rare disease field ») is a three-year project starting in 2016 funded via the E-Rare 3 ERA-NET. This project builds on three resources largely adopted by the RD community: Orphanet, its ontology ORDO (the Orphanet Rare Disease Ontology), HPO (the Human Phenotype Ontology) and PhenoTips, with the support of outstanding bio-ontologies players, the European Bioinformatics Institute and the Garvan Institute. The project aims to provide the community with an integrated, RD-specific bio-informatics ecosystem that will harmonse the way phenomics information is stored in databases and patient files worldwide, and thereby contribute to interoperability. This ecosystem will consist of a suite of tools and ontologies, optimised to work together, made available through commonly used software repositories.
The HIPBI-RD ecosystem will contribute to the interpretation of variants identified through exome and full genome sequencing by harmonising the way phenotypic information is collected, thus improving diagnostics. The ultimate goal of HIPBI-RD is to provide a resource that will contribute to bridging genome-scale biology and a disease-centered view on human pathobiology.
Acknowledgements:
This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under the ERA-NET Cofund action N° 643578, E-Rare3. The project is co-funded by the French National Research Agency (ANR), the German Federal Ministry of Education and Research (BMBF), German Research Foundation (DFG), and the Canadian Institutes for Health Research (CIHR)EV_Core
This document provides information about extracellular vesicles (EVs), the EV Core at the University of Helsinki, and its services. It summarizes that:
1) EVs are membrane vesicles released by cells that contain proteins, nucleic acids, lipids, and metabolites reflective of the cell's state and can influence recipient cells.
2) The EV Core is a collaboration between departments at the University of Helsinki focused on understanding how EVs regulate cell behavior and could be used for diagnostics or therapeutics.
3) The EV Core provides EV isolation, quantification, characterization and "omics" services using optimized methods and expertise in areas such as EV production, purification, analysis, and standardization.
2016 11-11_TSRI News Release
Macrophages, immune cells, may help tumors grow by forming primitive vascular channels. Researchers discovered that macrophages can create vessel-like structures in tumors to deliver oxygen and nutrients, representing a new potential cancer treatment target. The macrophage-formed conduits have a distinct architecture from blood vessels and appear too small for red blood cells, but may transport dissolved oxygen and glucose in oxygen-deprived tumor environments. Targeting macrophage activity in addition to current anti-angiogenesis drugs could provide a new approach to starving tumors.
Georges Dagher
The document summarizes the European Research Infrastructure for Biobanking and Biomolecular Resources (BBMRI) preparatory phase project. It discusses how biobanks across Europe have historically been small and heterogeneous, hindering modern genetic research. The BBMRI aims to integrate existing biobanks and resources to create a large pan-European infrastructure following common standards. The preparatory phase involved over 50 institutions from 28 countries to assess resources and technologies and develop plans for a sustainable infrastructure to support research.
Ongoing Lung Cancer Clinical Trials at the Markey Cancer Center
Sherif Mohamed El-Refai is a current PhD student in pharmaceutical sciences at the University of Kentucky, where he focuses his studies on clinical and experimental therapeutics. Sherif Mohamed El-Refai also conducts oncology research at the University of Kentucky Hospital, which is home to the Markey Cancer Center. To develop innovative ways to fight lung cancer, the Markey Cancer Center and the University of Kentucky are currently sponsoring a number of lung cancer trials.
Call for papers 2015 american scientific research journal for engineering, t...
Call for papers 2015 american scientific research journal for engineering, technology, and sciences (asrjets)
1.3 guillaume dumenil
This document discusses the critical stages that bacteria must go through to cause septicemia, including colonizing the arterial wall. It focuses on using Neisseria meningitidis as a model. There are three main stages: 1) bacteria adhere to sites determined by shear stress levels, targeting the cerebral microcirculation; 2) an intense cross-talk occurs between cells and bacteria to resist shear stress through cellular protrusions and biofilm-like structures; 3) detachment is a highly regulated process that is a potential therapeutic target through modifying type IV pili. Developing new models is needed to better study these infection processes.
NADIR: the European “Network for Animal Diseases Infectiology Research” faci...
NADIR: the European “Network for Animal Diseases Infectiology Research” faci...Global Risk Forum GRFDavos
The document describes the NADIR project, a European network of animal disease research facilities. The objectives of NADIR are to 1) promote collaboration between animal research centers, 2) facilitate research to improve existing facilities, and 3) provide transnational access to external researchers. NADIR received 7.5 million euros in funding to coordinate its 17 partner institutions over 5 years. Activities included networking exchanges, joint research projects, and providing access to facilities for 45 external research projects covering various animal species and disease topics. The project aims to optimize European research on infectious livestock diseases and zoonoses.Recommended
HIPBI-RD: Harmonising phenomics information for a better interoperability in ...
HIPBI-RD: Harmonising phenomics information for a better interoperability in ...Human Variome Project
Rare disease (RD) research is a field of medicine increasingly reliant on information technology, with the advent of low-cost whole-genome sequencing revolutionising the discovery of genetic causes of disorders. Detailed phenotype data, combined with genomic data, have an enormous potential to accelerate the identification of clinically actionable prognostic or therapeutic implications and to improve our understanding of RD. The harmonisation of phenomics information, including disorders and phenotype traits that are stored in different contexts in a non-standardised way, is a cornerstone for producing sound data to foster research.
HIPBI-RD («Harmonising phenomics information for a better interoperability in the rare disease field ») is a three-year project starting in 2016 funded via the E-Rare 3 ERA-NET. This project builds on three resources largely adopted by the RD community: Orphanet, its ontology ORDO (the Orphanet Rare Disease Ontology), HPO (the Human Phenotype Ontology) and PhenoTips, with the support of outstanding bio-ontologies players, the European Bioinformatics Institute and the Garvan Institute. The project aims to provide the community with an integrated, RD-specific bio-informatics ecosystem that will harmonse the way phenomics information is stored in databases and patient files worldwide, and thereby contribute to interoperability. This ecosystem will consist of a suite of tools and ontologies, optimised to work together, made available through commonly used software repositories.
The HIPBI-RD ecosystem will contribute to the interpretation of variants identified through exome and full genome sequencing by harmonising the way phenotypic information is collected, thus improving diagnostics. The ultimate goal of HIPBI-RD is to provide a resource that will contribute to bridging genome-scale biology and a disease-centered view on human pathobiology.
Acknowledgements:
This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under the ERA-NET Cofund action N° 643578, E-Rare3. The project is co-funded by the French National Research Agency (ANR), the German Federal Ministry of Education and Research (BMBF), German Research Foundation (DFG), and the Canadian Institutes for Health Research (CIHR)EV_Core
This document provides information about extracellular vesicles (EVs), the EV Core at the University of Helsinki, and its services. It summarizes that:
1) EVs are membrane vesicles released by cells that contain proteins, nucleic acids, lipids, and metabolites reflective of the cell's state and can influence recipient cells.
2) The EV Core is a collaboration between departments at the University of Helsinki focused on understanding how EVs regulate cell behavior and could be used for diagnostics or therapeutics.
3) The EV Core provides EV isolation, quantification, characterization and "omics" services using optimized methods and expertise in areas such as EV production, purification, analysis, and standardization.
2016 11-11_TSRI News Release
Macrophages, immune cells, may help tumors grow by forming primitive vascular channels. Researchers discovered that macrophages can create vessel-like structures in tumors to deliver oxygen and nutrients, representing a new potential cancer treatment target. The macrophage-formed conduits have a distinct architecture from blood vessels and appear too small for red blood cells, but may transport dissolved oxygen and glucose in oxygen-deprived tumor environments. Targeting macrophage activity in addition to current anti-angiogenesis drugs could provide a new approach to starving tumors.
Georges Dagher
The document summarizes the European Research Infrastructure for Biobanking and Biomolecular Resources (BBMRI) preparatory phase project. It discusses how biobanks across Europe have historically been small and heterogeneous, hindering modern genetic research. The BBMRI aims to integrate existing biobanks and resources to create a large pan-European infrastructure following common standards. The preparatory phase involved over 50 institutions from 28 countries to assess resources and technologies and develop plans for a sustainable infrastructure to support research.
Ongoing Lung Cancer Clinical Trials at the Markey Cancer Center
Sherif Mohamed El-Refai is a current PhD student in pharmaceutical sciences at the University of Kentucky, where he focuses his studies on clinical and experimental therapeutics. Sherif Mohamed El-Refai also conducts oncology research at the University of Kentucky Hospital, which is home to the Markey Cancer Center. To develop innovative ways to fight lung cancer, the Markey Cancer Center and the University of Kentucky are currently sponsoring a number of lung cancer trials.
Call for papers 2015 american scientific research journal for engineering, t...
Call for papers 2015 american scientific research journal for engineering, technology, and sciences (asrjets)
1.3 guillaume dumenil
This document discusses the critical stages that bacteria must go through to cause septicemia, including colonizing the arterial wall. It focuses on using Neisseria meningitidis as a model. There are three main stages: 1) bacteria adhere to sites determined by shear stress levels, targeting the cerebral microcirculation; 2) an intense cross-talk occurs between cells and bacteria to resist shear stress through cellular protrusions and biofilm-like structures; 3) detachment is a highly regulated process that is a potential therapeutic target through modifying type IV pili. Developing new models is needed to better study these infection processes.
NADIR: the European “Network for Animal Diseases Infectiology Research” faci...
NADIR: the European “Network for Animal Diseases Infectiology Research” faci...Global Risk Forum GRFDavos
The document describes the NADIR project, a European network of animal disease research facilities. The objectives of NADIR are to 1) promote collaboration between animal research centers, 2) facilitate research to improve existing facilities, and 3) provide transnational access to external researchers. NADIR received 7.5 million euros in funding to coordinate its 17 partner institutions over 5 years. Activities included networking exchanges, joint research projects, and providing access to facilities for 45 external research projects covering various animal species and disease topics. The project aims to optimize European research on infectious livestock diseases and zoonoses.Julio E. Celis-Investigar, educar, dialogar
'Investigar, educar, dialogar. Las lecciones que aprendimos de José Mariano Gago (1948-2015)'. Con este título celebramos los días 1 y 2 de junio de 2016 en la Fundación Ramón Areces un simposio para homenajear la trayectoria de quien fue ministro de Ciencia y Tecnología (1995-2002) y ministro de Ciencia, Tecnología y Educación Superior (2005-2011) de Portugal. Gago desempeñó una labor crucial en el diseño de los planes de desarrollo de la ciencia, la tecnología y la innovación, no solo en su país sino en toda Europa.
HEVnet: Sharing sequences & metadata of hepatitis E virus
HEVnet network & database.
A global network of scientists sharing molecular & epidemiological data on hepatitis E virus.
Presented by Agnetha Hofhuis, on behalf of HEVnet.
@hev expert meeting ECDC November 2018
Session 13 francesc_palau
This document discusses determinants and considerations for research on rare diseases from multiple perspectives. It notes both social and medical reasons for studying rare diseases, as they can provide insights into normal biological processes. An integrated and multidisciplinary approach is advocated, involving collaboration between basic and clinical researchers, as well as engagement with patient organizations, healthcare systems, and political actors to help foster research plans and infrastructure at both national and European levels.
Since January Elsevier has created a COVID-19 resource center with...
The document summarizes recommendations from 13 urological associations/societies (UASs) regarding prioritization of urological procedures during the COVID-19 pandemic. Four UASs were international and nine were European national associations. There was broad consensus that prostate biopsies for suspected lower-risk prostate cancer and elective procedures for benign conditions should be deferred. Most UASs also recommended deferring elective surgeries for lower-risk prostate cancer and kidney cancer, non-obstructing kidney stones, and benign prostatic hyperplasia. The expected changes are likely to significantly increase urologists' workload regarding consultations, surgical waitlists, and resource allocation in the future.
Bokk+final+du+10+juin+2011
Professeur Jean-François Delfraissy, ITMO IMMI, Paris
1. New mechanisms/paradigms
Moderators: François Loïc Cosset, Lyon and Olivier Schwartz,
Institut Pasteur Paris
Speakers: Philippe Sansonnetti, Institut Pasteur Paris :
From bugs and men to treatments and vaccines
Eric Oswald, Toulouse: Escherichia coli: the enemy within
Stéphanie Blandin, Strasbourg: Towards new approaches
to control malaria gambiae
Marc Lecuit, Institut Pasteur Paris: Microbes and host barriers
Ivo Gomperts
Lab'InSight Toxicological Risk Assessment UCL - LTAP 24.10.2013
Lab'InSight Toxicological Risk Assessment UCL - LTAP 24.10.2013Réseau LIEU (Liaison Entreprises-Universités)
The document summarizes the work of the Louvain Centre for Toxicology and Applied Pharmacology (LTAP) at the Université catholique de Louvain. The LTAP conducts research on toxicological risk assessment through various areas of expertise, including developing non-invasive biomarkers to detect environmental pollutants, evaluating health hazards of chemicals, and studying emerging risks like nanoparticles and carbon nanotubes. It also meta-analyzes data from multiple studies and has conducted research on risks from low levels of cadmium, indium, and pesticides. The LTAP aims to provide independent, high-quality scientific research that can be applied to toxicological risk assessment.FAO partnerships on health risk and control of influenza and emerging zoonoses
FAO partnerships on health risk and control of influenza and emerging zoonosesTariq Mustafa Mohamed Ali
This document outlines FAO's partnerships and collaborations on controlling influenza and emerging zoonotic diseases, including its work on OFFLU. It discusses FAO's role in the Global Framework for Progressive Control of Transboundary Animal Diseases and the Global Early Warning System. It also provides an overview of OFFLU's objectives, technical expertise areas, and projects. Finally, it describes FAO's collaboration with WHO at the animal-human interface under the One Health approach.Session 13 francesc_palau
This document summarizes the keynote presentation on determinants for research on rare diseases given at the 5th European Conference on Rare Diseases. The presentation outlined several factors that are important for rare disease research, including the human, financial, training, healthcare, social, and political factors. It emphasized the need for a multidisciplinary and integrative approach involving national centers of expertise, clinical and basic research, registries, biobanks, and databases to advance understanding and treatment of rare diseases. Supranational collaboration through European networks of centers of expertise and platforms/infrastructures was also highlighted as important for fostering rare disease research.
Cairo Atmc 8 Prosp
The document discusses the role and activities of the Institut National de la Transfusion Sanguine (INTS) in France. It provides an overview of the INTS, highlighting that it is the French national institute of blood transfusion with a three-fold role in research, reference, and education/training. It also summarizes some of the INTS's key activities, such as its laboratories, international involvement, education programs including higher degrees and continuing medical education, and a focus on e-learning.
One World - One Health presentation Katinka de Balogh FAO
During the FVE conference in Brussels on April 7, 2014, Katinka de Balogh, leader the global Veterinary Public Health activities of the FAO, presented the One-Health approach to highlight the importance of prevention, ensuring health and welfare of people and animals in a globalized environment:
• The benefit coming from the implementation of good health management in practice, both in terms of health and welfare, as well as, of financial sustainability
• The importance of coordinating actions in both sectors via a One-Health approach, with a particular focus on zoonotic diseases
• The role of the medical and veterinary profession in assuring these matters and educating the society
Katinka de Balogh is of Dutch and Hungarian origins and grew up in Latin-America. She studied veterinary medicine in Berlin and Munich and graduated and obtained her doctorate in tropical parasitology from the Tropical Institute of the University of Munich in 1984. In the late 80’s she had spent two years as a young professional at the Veterinary Public Health Unit of the World Health Organization (WHO) in Geneva. In 2002 she started working at the Food and Agriculture Organization of the United Nations (FAO) in Rome.
1.0 jean-françois delfraissy intro
Infectious diseases account for a significant portion of global mortality, particularly in developing countries. New pathogens are emerging and spreading rapidly, while multidrug-resistant pathogens are a growing problem. A multidisciplinary approach is needed to address infectious disease challenges. This document outlines the agenda for the 3rd International Research Meeting on microbiology and infectious diseases, highlighting France's major research institutions in this area and the scientific sessions to be covered.
Standards for public health genomic epidemiology - Biocuration 2015
A presentation introducing genomic epidemiology and its application in public health. It also explains the need for standards to support the Canadian Integrated Rapid Infectious Disease Analysis platform which implements genomic epidemiology analyses for detection and investigation of infectious disease outbreaks caused by food-borne pathogens.
L'Institut Pasteur de Tunis
The Institut Pasteur de Tunis (IPT) is a biomedical research institution dedicated to public health. It was founded in 1893 and has made major discoveries in diseases such as typhus, toxoplasmosis, and leishmaniasis. The IPT conducts research, vaccine and serum production, clinical analysis, training, and technology transfer. It has over 470 employees including 123 scientists. The IPT is part of the international Pasteur network and collaborates with national and international partners on research projects and training programs.
A Comprehensive Fracture Prevention Strategy In Older Adults The European Un...
This document lists over 100 authors and their affiliations who are members of the European Union Geriatric Medicine Society (EUGMS) Falls and Fracture Interest Group or the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO), Osteoporosis Research and Information Group (GRIO), and International osteoporosis Foundation (IOF). The authors are from various universities, hospitals, and research institutions in Europe, North America, Asia, and other parts of the world. They are involved in research related to falls, fractures, osteoporosis, and bone health in older adults. The document provides contact information for each author such as their department
Global health - People, animals, plants, the environment: towards an integrat...
Global health - People, animals, plants, the environment: towards an integrat...Agropolis International
This document provides an overview of integrated approaches to health from the scientific community in the Occitanie region of France. It discusses how integrated health looks at human health as interconnected with animal and environmental health. It describes the factors involved in disease emergence and transmission, including pathogens, reservoirs, vectors, interfaces, and mechanisms of change over time. The scientific community in Occitanie studies these factors across human, animal, plant and environmental health through various research laboratories. The document also discusses how integrated approaches consider food systems and global health.Apresentação Unesp - PPT
Universidade Estadual Paulista "Júlio de Mesquita Filho" (UNESP) is a public university system in São Paulo, Brazil with 23 campuses across the state. It has over 50,000 students and offers degrees in health sciences, engineering, humanities, and other fields. UNESP engages in research collaborations both within Brazil and internationally and focuses on areas such as bioenergy, ocean science, and biotechnology.
Alcohol intake and breast cancer in the European prospective investigation in...
Alcohol intake and breast cancer in the European prospective investigation in...BARRY STANLEY 2 fasd
1) This study investigated the relationship between alcohol intake and breast cancer risk using data from over 330,000 women in the European Prospective Investigation into Cancer and Nutrition cohort study followed for an average of 11 years.
2) The study found a significant association between higher alcohol intake and increased breast cancer risk, with a 4.2% increase in risk for every 10 grams of alcohol consumed per day. Intake of 5-15 grams per day was associated with a 5.9% higher risk compared to intake of 0-5 grams per day.
3) The increased risks were seen for both hormone receptor positive and negative breast tumor subtypes, and the risks were stronger among women who started drinking before their first fullWork Package (WP) 12 – PEARL Barriers In search for an inventory and assessme...
http://www.fao.org/about/meetings/wgs-on-food-safety-management/en/
International challenges regarding the future sharing of sequence data. Presentation from the Technical Meeting on the impact of Whole Genome Sequencing (WGS) on food safety management and GMI-9, 23-25 May 2016, Rome, Italy.
Hellenic Innovation Forum 2017, Elpen papalois
The Experimental – Research Center of Elpen Pharmaceuticals was established in 1996. It has facilities and equipment for biomedical and pharmaceutical research as well as medical training. The center engages in research partnerships, international collaborations, preclinical testing, and medical training. It has over 500 licenses for experimentation and has engaged in over 350 research projects and theses.
PHINDaccess Conference Omics Challenges in Infectious Diseases Research - K...
PHINDaccess Conference
Omics Challenges in Infectious Diseases Research
- Kick off meeting - November 5, 2018
The relationship between_health_and_growth
This paper revisits the relationship between health and growth in light of modern endogenous growth theory. We propose an unified framework that encompasses the growth effects of both, the accumulation and the level of health. Based on cross-country regressions where we instrument for both variables, we find that a higher initial level and a higher rate of improvement in life expectancy, both have a significantly positive impact on per capita GDP growth.
Policies for conflicts_of_interest_lir_2011
In its role of think tank and within the framework of the “Assises du Médicament”, the LIR considered useful to make realize by the researchers of the ESSEC an international study on the policies of management of conflicts of interests.
Four reglementations were studied : United States, Great Britain, Germany and Sweden.
More Related Content
Similar to 0.1 andr syrota
Julio E. Celis-Investigar, educar, dialogar
'Investigar, educar, dialogar. Las lecciones que aprendimos de José Mariano Gago (1948-2015)'. Con este título celebramos los días 1 y 2 de junio de 2016 en la Fundación Ramón Areces un simposio para homenajear la trayectoria de quien fue ministro de Ciencia y Tecnología (1995-2002) y ministro de Ciencia, Tecnología y Educación Superior (2005-2011) de Portugal. Gago desempeñó una labor crucial en el diseño de los planes de desarrollo de la ciencia, la tecnología y la innovación, no solo en su país sino en toda Europa.
HEVnet: Sharing sequences & metadata of hepatitis E virus
HEVnet network & database.
A global network of scientists sharing molecular & epidemiological data on hepatitis E virus.
Presented by Agnetha Hofhuis, on behalf of HEVnet.
@hev expert meeting ECDC November 2018
Session 13 francesc_palau
This document discusses determinants and considerations for research on rare diseases from multiple perspectives. It notes both social and medical reasons for studying rare diseases, as they can provide insights into normal biological processes. An integrated and multidisciplinary approach is advocated, involving collaboration between basic and clinical researchers, as well as engagement with patient organizations, healthcare systems, and political actors to help foster research plans and infrastructure at both national and European levels.
Since January Elsevier has created a COVID-19 resource center with...
The document summarizes recommendations from 13 urological associations/societies (UASs) regarding prioritization of urological procedures during the COVID-19 pandemic. Four UASs were international and nine were European national associations. There was broad consensus that prostate biopsies for suspected lower-risk prostate cancer and elective procedures for benign conditions should be deferred. Most UASs also recommended deferring elective surgeries for lower-risk prostate cancer and kidney cancer, non-obstructing kidney stones, and benign prostatic hyperplasia. The expected changes are likely to significantly increase urologists' workload regarding consultations, surgical waitlists, and resource allocation in the future.
Bokk+final+du+10+juin+2011
Professeur Jean-François Delfraissy, ITMO IMMI, Paris
1. New mechanisms/paradigms
Moderators: François Loïc Cosset, Lyon and Olivier Schwartz,
Institut Pasteur Paris
Speakers: Philippe Sansonnetti, Institut Pasteur Paris :
From bugs and men to treatments and vaccines
Eric Oswald, Toulouse: Escherichia coli: the enemy within
Stéphanie Blandin, Strasbourg: Towards new approaches
to control malaria gambiae
Marc Lecuit, Institut Pasteur Paris: Microbes and host barriers
Ivo Gomperts
Lab'InSight Toxicological Risk Assessment UCL - LTAP 24.10.2013
Lab'InSight Toxicological Risk Assessment UCL - LTAP 24.10.2013Réseau LIEU (Liaison Entreprises-Universités)
The document summarizes the work of the Louvain Centre for Toxicology and Applied Pharmacology (LTAP) at the Université catholique de Louvain. The LTAP conducts research on toxicological risk assessment through various areas of expertise, including developing non-invasive biomarkers to detect environmental pollutants, evaluating health hazards of chemicals, and studying emerging risks like nanoparticles and carbon nanotubes. It also meta-analyzes data from multiple studies and has conducted research on risks from low levels of cadmium, indium, and pesticides. The LTAP aims to provide independent, high-quality scientific research that can be applied to toxicological risk assessment.FAO partnerships on health risk and control of influenza and emerging zoonoses
FAO partnerships on health risk and control of influenza and emerging zoonosesTariq Mustafa Mohamed Ali
This document outlines FAO's partnerships and collaborations on controlling influenza and emerging zoonotic diseases, including its work on OFFLU. It discusses FAO's role in the Global Framework for Progressive Control of Transboundary Animal Diseases and the Global Early Warning System. It also provides an overview of OFFLU's objectives, technical expertise areas, and projects. Finally, it describes FAO's collaboration with WHO at the animal-human interface under the One Health approach.Session 13 francesc_palau
This document summarizes the keynote presentation on determinants for research on rare diseases given at the 5th European Conference on Rare Diseases. The presentation outlined several factors that are important for rare disease research, including the human, financial, training, healthcare, social, and political factors. It emphasized the need for a multidisciplinary and integrative approach involving national centers of expertise, clinical and basic research, registries, biobanks, and databases to advance understanding and treatment of rare diseases. Supranational collaboration through European networks of centers of expertise and platforms/infrastructures was also highlighted as important for fostering rare disease research.
Cairo Atmc 8 Prosp
The document discusses the role and activities of the Institut National de la Transfusion Sanguine (INTS) in France. It provides an overview of the INTS, highlighting that it is the French national institute of blood transfusion with a three-fold role in research, reference, and education/training. It also summarizes some of the INTS's key activities, such as its laboratories, international involvement, education programs including higher degrees and continuing medical education, and a focus on e-learning.
One World - One Health presentation Katinka de Balogh FAO
During the FVE conference in Brussels on April 7, 2014, Katinka de Balogh, leader the global Veterinary Public Health activities of the FAO, presented the One-Health approach to highlight the importance of prevention, ensuring health and welfare of people and animals in a globalized environment:
• The benefit coming from the implementation of good health management in practice, both in terms of health and welfare, as well as, of financial sustainability
• The importance of coordinating actions in both sectors via a One-Health approach, with a particular focus on zoonotic diseases
• The role of the medical and veterinary profession in assuring these matters and educating the society
Katinka de Balogh is of Dutch and Hungarian origins and grew up in Latin-America. She studied veterinary medicine in Berlin and Munich and graduated and obtained her doctorate in tropical parasitology from the Tropical Institute of the University of Munich in 1984. In the late 80’s she had spent two years as a young professional at the Veterinary Public Health Unit of the World Health Organization (WHO) in Geneva. In 2002 she started working at the Food and Agriculture Organization of the United Nations (FAO) in Rome.
1.0 jean-françois delfraissy intro
Infectious diseases account for a significant portion of global mortality, particularly in developing countries. New pathogens are emerging and spreading rapidly, while multidrug-resistant pathogens are a growing problem. A multidisciplinary approach is needed to address infectious disease challenges. This document outlines the agenda for the 3rd International Research Meeting on microbiology and infectious diseases, highlighting France's major research institutions in this area and the scientific sessions to be covered.
Standards for public health genomic epidemiology - Biocuration 2015
A presentation introducing genomic epidemiology and its application in public health. It also explains the need for standards to support the Canadian Integrated Rapid Infectious Disease Analysis platform which implements genomic epidemiology analyses for detection and investigation of infectious disease outbreaks caused by food-borne pathogens.
L'Institut Pasteur de Tunis
The Institut Pasteur de Tunis (IPT) is a biomedical research institution dedicated to public health. It was founded in 1893 and has made major discoveries in diseases such as typhus, toxoplasmosis, and leishmaniasis. The IPT conducts research, vaccine and serum production, clinical analysis, training, and technology transfer. It has over 470 employees including 123 scientists. The IPT is part of the international Pasteur network and collaborates with national and international partners on research projects and training programs.
A Comprehensive Fracture Prevention Strategy In Older Adults The European Un...
This document lists over 100 authors and their affiliations who are members of the European Union Geriatric Medicine Society (EUGMS) Falls and Fracture Interest Group or the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO), Osteoporosis Research and Information Group (GRIO), and International osteoporosis Foundation (IOF). The authors are from various universities, hospitals, and research institutions in Europe, North America, Asia, and other parts of the world. They are involved in research related to falls, fractures, osteoporosis, and bone health in older adults. The document provides contact information for each author such as their department
Global health - People, animals, plants, the environment: towards an integrat...
Global health - People, animals, plants, the environment: towards an integrat...Agropolis International
This document provides an overview of integrated approaches to health from the scientific community in the Occitanie region of France. It discusses how integrated health looks at human health as interconnected with animal and environmental health. It describes the factors involved in disease emergence and transmission, including pathogens, reservoirs, vectors, interfaces, and mechanisms of change over time. The scientific community in Occitanie studies these factors across human, animal, plant and environmental health through various research laboratories. The document also discusses how integrated approaches consider food systems and global health.Apresentação Unesp - PPT
Universidade Estadual Paulista "Júlio de Mesquita Filho" (UNESP) is a public university system in São Paulo, Brazil with 23 campuses across the state. It has over 50,000 students and offers degrees in health sciences, engineering, humanities, and other fields. UNESP engages in research collaborations both within Brazil and internationally and focuses on areas such as bioenergy, ocean science, and biotechnology.
Alcohol intake and breast cancer in the European prospective investigation in...
Alcohol intake and breast cancer in the European prospective investigation in...BARRY STANLEY 2 fasd
1) This study investigated the relationship between alcohol intake and breast cancer risk using data from over 330,000 women in the European Prospective Investigation into Cancer and Nutrition cohort study followed for an average of 11 years.
2) The study found a significant association between higher alcohol intake and increased breast cancer risk, with a 4.2% increase in risk for every 10 grams of alcohol consumed per day. Intake of 5-15 grams per day was associated with a 5.9% higher risk compared to intake of 0-5 grams per day.
3) The increased risks were seen for both hormone receptor positive and negative breast tumor subtypes, and the risks were stronger among women who started drinking before their first fullWork Package (WP) 12 – PEARL Barriers In search for an inventory and assessme...
http://www.fao.org/about/meetings/wgs-on-food-safety-management/en/
International challenges regarding the future sharing of sequence data. Presentation from the Technical Meeting on the impact of Whole Genome Sequencing (WGS) on food safety management and GMI-9, 23-25 May 2016, Rome, Italy.
Hellenic Innovation Forum 2017, Elpen papalois
The Experimental – Research Center of Elpen Pharmaceuticals was established in 1996. It has facilities and equipment for biomedical and pharmaceutical research as well as medical training. The center engages in research partnerships, international collaborations, preclinical testing, and medical training. It has over 500 licenses for experimentation and has engaged in over 350 research projects and theses.
PHINDaccess Conference Omics Challenges in Infectious Diseases Research - K...
PHINDaccess Conference
Omics Challenges in Infectious Diseases Research
- Kick off meeting - November 5, 2018
Similar to 0.1 andr syrota (20)
HEVnet: Sharing sequences & metadata of hepatitis E virus
HEVnet: Sharing sequences & metadata of hepatitis E virus
Since January Elsevier has created a COVID-19 resource center with...
Since January Elsevier has created a COVID-19 resource center with...
Lab'InSight Toxicological Risk Assessment UCL - LTAP 24.10.2013
Lab'InSight Toxicological Risk Assessment UCL - LTAP 24.10.2013
FAO partnerships on health risk and control of influenza and emerging zoonoses
FAO partnerships on health risk and control of influenza and emerging zoonoses
One World - One Health presentation Katinka de Balogh FAO
One World - One Health presentation Katinka de Balogh FAO
Standards for public health genomic epidemiology - Biocuration 2015
Standards for public health genomic epidemiology - Biocuration 2015
A Comprehensive Fracture Prevention Strategy In Older Adults The European Un...
A Comprehensive Fracture Prevention Strategy In Older Adults The European Un...
Global health - People, animals, plants, the environment: towards an integrat...
Global health - People, animals, plants, the environment: towards an integrat...
Alcohol intake and breast cancer in the European prospective investigation in...
Alcohol intake and breast cancer in the European prospective investigation in...
Work Package (WP) 12 – PEARL Barriers In search for an inventory and assessme...
Work Package (WP) 12 – PEARL Barriers In search for an inventory and assessme...
PHINDaccess Conference Omics Challenges in Infectious Diseases Research - K...
PHINDaccess Conference Omics Challenges in Infectious Diseases Research - K...
More from Association LIR
The relationship between_health_and_growth
This paper revisits the relationship between health and growth in light of modern endogenous growth theory. We propose an unified framework that encompasses the growth effects of both, the accumulation and the level of health. Based on cross-country regressions where we instrument for both variables, we find that a higher initial level and a higher rate of improvement in life expectancy, both have a significantly positive impact on per capita GDP growth.
Policies for conflicts_of_interest_lir_2011
In its role of think tank and within the framework of the “Assises du Médicament”, the LIR considered useful to make realize by the researchers of the ESSEC an international study on the policies of management of conflicts of interests.
Four reglementations were studied : United States, Great Britain, Germany and Sweden.
Observatoire bipe presentation_presse
Travaux LIR-BIPE présentés à la Presse le 24 septembre 2009 sur
Le Marché du Médicament remboursable (S1-2009) et la Consommation de médicaments en France
Impact sur la_longevite_et_croissance_economique
Les déficits cumulés de notre système d’assurance maladie, le vieillissement de notre population, l’augmentation de son espérance de vie, et l’augmentation des coûts associés à l’apparition de nouveaux équipements, posent avec acuité le problème du financement des dépenses de santé.
Si différentes réformes ont été introduites au cours des dernières années pour stabiliser nos dépenses de santé, les effets potentiels sur le secteur de la santé, l’innovation dans les industries et la croissance, ont trop rarement fait l’objet d’analyses approfondies.
Etude enjeux-vieillissement
Maladie d’Alzheimer, accident vasculaire cérébral, arthrose... Autant de pathologies que chacun d’entre nous connaît, parce qu’elles peuvent toucher une relation, un ami, un parent. Toutefois, la perception qu’on peut en avoir lorsqu’un de nos proches est affecté est largement indépendante du poids de la maladie dans la population générale même si elle est bien évidemment liée aux modalités actuelles de prise en charge.
Enquete attractivite-lir leem-aec
Capitaliser sur les résultats de l’Enquête 2008
Attractivité de la France au sein de la Recherche Clinique Internationale conduite par le Leem pour conduire une analyse comparative
entre les données des adhérents du LIR
et celles de l’ensemble des participants de l’Industrie
Consommation de medicaments_dans_5_pays_europeens
Le niveau de consommation de médicaments en France est souvent considéré comme étant l’un des plus importants d’Europe. Cette étude cherche à vérifier la persistance de cette affirmation sur la période 2000-2004 en comparant les niveaux de consommation de 7 classes de médicaments en Allemagne, Espagne, France, Italie et Royaume-Uni. Non seulement la France n’était plus en 2004 le premier consommateur dans les 7 classes étudiées mais on constate un rapprochement aussi bien des niveaux de consommation que des structures de consommation entre les 5 pays.
Prise en-charge-personnes-agees
Quelle prise en charge sanitaire et médico-sociale des personnes âgées, Quelle anticipation des besoins futurs ?
Dp debats femmes-et_sante
une enquête auprès des Françaises pour voir comment elles perçoivent l’avenir du système de santé
Publication ph-aghion-croissance-et-sante
1) The document discusses the relationship between health and economic growth, drawing on both the Lucas and Nelson-Phelps approaches. It proposes a theoretical framework that encompasses both the level and accumulation of health as factors that can impact growth.
2) Empirically, using cross-country regressions and instruments from previous studies, the document finds that both the initial level and rate of improvement in life expectancy have a significantly positive impact on GDP growth.
3) Looking specifically at OECD countries, the document finds evidence that only reductions in mortality below age 40 (not overall mortality improvements) generate productivity gains that explain the positive health-growth relationship.
Policies for conflicts_of_interest
This document summarizes policies for managing conflicts of interest in health systems from four countries: the United States, United Kingdom, Germany, and Sweden. It defines a conflict of interest and discusses who such policies apply to, including both internal employees and external experts/contractors. It examines the types of interests that should be declared, such as pecuniary and non-pecuniary interests as well as family interests. The document also outlines when and how interests should be declared, either upon appointment, before meetings, or annually. Finally, it notes some of the challenges around setting appropriate limits for interest declarations.
Lir2011 discours vpecresse-
1. The document discusses a speech given by a French Minister to an international pharmaceutical research group about France's efforts to combat infectious diseases through increased medical research funding and public-private partnerships.
2. Over the past 4 years, France has massively increased funding for medical research and provided tax incentives to encourage partnerships between public research laboratories and private companies.
3. Key initiatives include the creation of a research alliance called AVIESAN to better coordinate resources and projects, as well as programs that provide over €1 billion in funding for projects related to biomedical research and technologies.
More from Association LIR (20)
Proposition+alliance+sur+info+patien+gp +assmed-avril2011
Proposition+alliance+sur+info+patien+gp +assmed-avril2011
Recently uploaded
PGx Analysis in VarSeq: A User’s Perspective
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
Acute Gout Care & Urate Lowering Therapy .pdf
In this document , the management of acute gout attacks and a description of urate lowering therapy is mentioned.
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
une 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfChulalongkorn Allergy and Clinical Immunology Research Group
Pollen and Fungal allergy
Presented by Chaloemchai Chumsaengchotsakul, MD.
June 14, 2024Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
What is Obesity? How to overcome Obesity?
Obesity is a chronic complex disease defined by excessive fat deposits that can impair health.
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...Université de Montréal
“Psychiatry and the Humanities”: An Innovative Course at the University of Montreal Expanding the medical model to embrace the humanities. Link: https://www.psychiatrictimes.com/view/-psychiatry-and-the-humanities-an-innovative-course-at-the-university-of-montrealFull Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...ayushrajshrivastava7
Regulatory Affairs
Full hand written notes
M.pharm - 1st year . Skin Diseases That Happen During Summer.
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.
SENSORY NEEDS B.SC. NURSING SEMESTER II.
Sensation is the neurological process by which we become aware of surrounding environment.
Foundation of Yoga, YCB Level-3, Unit-1
Unit -1 of Yoga certification board, level 3, all topics covered. An exam conducted by ministry of Ayush for yoga enthusiastic students.
How to Control Your Asthma Tips by gokuldas hospital.
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
Giloy in Ayurveda - Classical Categorization and Synonyms
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
Breast cancer: Post menopausal endocrine therapy
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
Know the difference between Endodontics and Orthodontics.
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
Top Travel Vaccinations in Manchester
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Recently uploaded (20)
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
Giloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and Synonyms
Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.
0.1 andr syrota
- 1. 3 rd International Biomedical Research Meeting June 10 th 2011 Résidence de Marigny Pr André Syrota
- 3. Ten Thematic Institutes covering the entire field of Life and health Sciences Neurosciences Cognitive Sciences Neurology, Psychiatry Genetics, Genomics Bioinformatics Immunology Hematology Respiratory diseases Microbiology Infectious diseases Public Health Health Technologies Cancer Cell Biology Development Molecular and Structural Biology Nutrition Circulation Metabolism Keywords: Sharing a common strategy to ensure an improved coordination
- 6. 35 billion € 21.9 devoted to Research and Higher education Investments for the future : a major opportunity for boosting R&I
- 10. www.aviesan.fr